Valuation Charles River Laboratories International, Inc. Berne S.E.

Stocks

Delayed Berne S.E. Other stock markets			5-day change	1st Jan Change
- ^CHF	-.--%		-.--%	-

06/06	Charles River Laboratories Has Potential to Outperform in 2H 2026, RBC Says	MT
04/06	Charles River Laboratories International, Inc. Presents at Jefferies Global Healthcare Conference 2026, Jun-03-2026 09:55 AM

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	18,941	11,138	12,252	9,520	10,023	9,032	-	-
Change	-	-41.2%	10%	-22.3%	5.29%	-9.89%	-	-
Enterprise Value (EV) ¹	21,366	13,616	14,622	11,565	11,946	10,844	10,500	10,123
Change	-	-36.28%	7.39%	-20.91%	3.29%	-9.22%	-3.18%	-3.59%
P/E Ratio	49.4x	23.1x	25.9x	931x	-70x	30.6x	20.4x	18.6x
PBR	7.45x	3.75x	3.41x	2.75x	3.17x	2.74x	2.49x	2.26x
PEG	-	0.9x	-9.44x	-9.5x	0x	-0x	0.4x	1.97x
Capitalization / Revenue	5.35x	2.8x	2.97x	2.35x	2.5x	2.34x	2.3x	2.2x
EV / Revenue	6.04x	3.42x	3.54x	2.86x	2.98x	2.81x	2.68x	2.47x
EV / EBITDA	24.3x	13.7x	14.4x	11.6x	12.3x	11x	10x	9.11x
EV / EBIT	28.8x	16.3x	17.4x	14.3x	15x	13.3x	11.9x	10.7x
EV / FCF	40.2x	46.2x	40x	23.1x	23x	31.2x	26.7x	42.3x
FCF Yield	2.49%	2.17%	2.5%	4.34%	4.34%	3.21%	3.74%	2.37%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	7.6	9.48	9.22	0.2	-2.91	6.135	9.2	10.07
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	3,540	3,976	4,129	4,050	4,015	3,855	3,924	4,105
EBITDA ¹	879.5	990.9	1,013	996.1	971.5	986.4	1,046	1,111
EBIT ¹	742.1	834	838.8	805.9	793.9	813.2	881	947.2
Net income ¹	391	486.2	474.6	10.3	-144.3	285.1	417.2	449
Net Debt ¹	2,425	2,477	2,370	2,046	1,923	1,812	1,468	1,091
Reference price ²	375.34	218.92	238.84	186.16	203.66	187.51	187.51	187.51
Nbr of stocks (in thousands)	50,464	50,879	51,297	51,136	49,215	48,168	-	-
Announcement Date	16/2/22	22/2/23	14/2/24	19/2/25	18/2/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
LONZA GROUP AG	29.71x	5.27x	16.33x	1.11%	42.96B
REVOLUTION MEDICINES, INC.	-18.77x	275.88x	-16.99x	-.--%	31.73B
IQVIA HOLDINGS INC.	22.03x	2.54x	10.97x	-.--%	30.22B
BEONE MEDICINES AG	38.83x	3.84x	24.59x	-.--%	28.94B
CELLTRION, INC.	28.09x	7.25x	18.65x	0.42%	23.87B
MEDPACE HOLDINGS, INC.	27.88x	4.48x	20.38x	-.--%	13.57B
EUROFINS SCIENTIFIC SE	22.34x	1.93x	8.51x	1.19%	12.96B
IONIS PHARMACEUTICALS, INC.	-20.61x	13.45x	-20.03x	-.--%	12.2B
Average	16.19x	39.33x	7.80x	0.34%	24.55B
Weighted average by Cap.	18.11x	48.82x	9.13x	0.37%